Abstract:Abstract Mitochondrial dynamics play vital roles in the tumorigenicity and malignancy of various types of cancers by promoting the tumor-initiating potential of cancer cells, suggesting that targeting crucial factors that drive mitochondrial dynamics may lead to promising anticancer therapies. In the current study, we report that overexpression of mitochondrial fission factor (MFF), which is upregulated significantly in liver cancer–initiating cells (LCIC), promotes mitochondrial fission and enhances stemness and tumor-initiating capability in non-LCICs. MFF-induced mitochondrial fission evoked mitophagy and asymmetric stem cell division and promoted a metabolic shift from oxidative phosphorylation to glycolysis that decreased mitochondrial reactive oxygen species (ROS) production, which prevented ROS-mediated degradation of the pluripotency transcription factor OCT4. CRISPR affinity purification in situ of regulatory elements showed that T-box transcription factor 19 (TBX19), which is overexpressed uniquely in LCICs compared with non-LCICs and liver progenitor cells, forms a complex with PRMT1 on the MFF promoter in LCICs, eliciting epigenetic histone H4R3me2a/H3K9ac-mediated transactivation of MFF. Targeting PRMT1 using furamidine, a selective pharmacologic inhibitor, suppressed TBX19-induced mitochondrial fission, leading to a profound loss of self-renewal potential and tumor-initiating capacity of LCICs. These findings unveil a novel mechanism underlying mitochondrial fission–mediated cancer stemness and suggest that regulation of mitochondrial fission via inhibition of PRMT1 may be an attractive therapeutic option for liver cancer treatment. Significance: These findings show that TBX19/PRMT1 complex–mediated upregulation of MFF promotes mitochondrial fission and tumor-initiating capacity in liver cancer cells, identifying PRMT1 as a viable therapeutic target in liver cancer.

MTFR2-dependent mitochondrial fission promotes HCC progression

Mitochondrial fission promotes cell migration by Ca 2+ /CaMKII/ERK/FAK pathway in hepatocellular carcinoma.

MFN1-dependent Alteration of Mitochondrial Dynamics Drives Hepatocellular Carcinoma Metastasis by Glucose Metabolic Reprogramming

Increased Mitochondrial Fission Promotes Autophagy and Hepatocellular Carcinoma Cell Survival Through the ROS-modulated Coordinated Regulation of the NFKB and TP53 Pathways

Mitochondrial dynamics and colorectal cancer biology: mechanisms and potential targets

Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis

Mitochondrial Fission-Induced Mtdna Stress Promotes Tumor-Associated Macrophage Infiltration and HCC Progression

The Role of Mitochondrial Dynamics and Mitophagy in Carcinogenesis, Metastasis and Therapy.

The Role of Mitochondrial Dynamics in Human Cancers.

FUNDC2 Promotes Liver Tumorigenesis by Inhibiting MFN1-mediated Mitochondrial Fusion

MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma

Drp1-mediated Mitochondrial Fission Promotes Cell Proliferation Through Crosstalk of P53 and NF-κB Pathways in Hepatocellular Carcinoma.

The role of mitochondria dynamics in human cancers

CCBE1 promotes mitochondrial fusion by inhibiting the TGF3-DRP1 axis to prevent the progression of hepatocellular carcinoma

Mitochondrial Fission Forms a Positive Feedback Loop with Cytosolic Calcium Signaling Pathway to Promote Autophagy in Hepatocellular Carcinoma Cells

CCBE1 promotes mitochondrial fusion by inhibiting the TGFβ-DRP1 axis to prevent the progression of hepatocellular carcinoma

Oxidative stress-mediated mitochondrial fission promotes hepatic stellate cell activation via stimulating oxidative phosphorylation

ZNF281 inhibits mitochondrial biogenesis to facilitate metastasis of hepatocellular carcinoma

Epigenetic Induction of Mitochondrial Fission Is Required for Maintenance of Liver Cancer–Initiating Cells

Research Progress on Mitochondria Regulating Tumor Immunity.

The role of mitochondrial dynamics in disease